100
Participants
Start Date
January 31, 2007
Primary Completion Date
December 31, 2008
Study Completion Date
December 31, 2008
Caspofungin
"Patients will receive caspofungin, starting from the first day of induction chemotherapy for leukemia, as a single daily dose intravenously at the dosage of 70 mg q.d. and followed by 50 mg q.d. thereafter until documentation of complete hematologic remission after the first induction cycle or of leukemia persistence after one cycle of induction and one cycle of salvage chemotherapy.~No stratification is planned."
Medicina Interna I Ospedale di Circolo, Varese
Divisione Ematologia Spedali Civili, Azienda Ospedaliera, Spedali Civili di Brescia, Brescia
Divisione Ematologia Ospedale Umberto I, Mestre
Dipartimento di Ematologia e Medicina Trasfusionale - Azienda Osp. Nazionale Santi Antonio e Biagio e Cesare Arrigo, Alessandria
USC Ematologia Ospedali Riuniti di Bergamo, Bergamo
Ematologia Centro TMO - Fondazione IRCSS Ospedale Maggiore, Milan
Ematologia - TMO - Ospedale San Gerardo, Monza
Ematologia 2 - Osp. Molinette San Giovanni Battista, Torino
Northern Italy Leukemia Group
OTHER